01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#HVO hVIVO PLC – Annual Report & Notice of AGM April 17, 2026 – Posted in: hVIVO (HVO)

London, UK – 17 April 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, confirms that the Company’s Annual Report and Accounts for the year ended 31 December 2025 and the Notice of Annual General Meeting (“AGM”) will be posted to shareholders today.   The 2025 Annual Report and Accounts, the Notice of AGM and accompanying form of proxy are available to download from the Company’s website: www.hvivo.com.  …

Continue reading

#VELA Technologies PLC – Result of AGM November 12, 2024 – Posted in: Vela Technologies Plc (VELA)

The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early stage and pre-IPO disruptive technology investments, announces that at its Annual General Meeting (“AGM”) held earlier today, all resolutions were duly passed. The proxy voting results of the resolutions are set out below: Resolutions at the Annual General Meeting Votes For* % of votes cast** Votes Against % of votes cast** Votes Withheld*** Total votes cast**** ORDINARY RESOLUTIONS 1. To receive and…

Continue reading

#TSP TruSpine Technologies PLC – Final Results September 30, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems, reports its full year results for the year ended 29 March 2024.   The Company continues to be in a pre-revenue development phase and remains loss making at this stage of its development. The loss before taxation for the year was £702k (2023: £853k) after administrative expenses of £656k (2023: £846k). The R&D tax…

Continue reading

#POLB Poolbeg Pharma PLC – Annual Report & AGM Notice May 9, 2024 – Posted in: Poolbeg Pharma (POLB)

9 May 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, confirms that the Company’s Annual Report and Accounts for the period ended 31 December 2023 and the notice of Annual General Meeting (“AGM”) will be posted to shareholders today.   The 2023 Annual Report and Accounts, the Notice of AGM and accompanying form of…

Continue reading

#VELA Vela Technologies – Investee Company #SKL Skill Cast Group PLC – Interim Results September 28, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

Skillcast (AIM: SKL), the provider of content and technology for digital compliance transformation, is pleased to announce its unaudited results for the six months ended 30 June 2022.  Highlights   6 months to 30 June 2022 (unaudited)  (H1 22)   6 months to 30 June 2021 (unaudited) (H1 21)   12 Months to 31 December 2021 (audited)   Change (H1 22 v H1 21) Revenue £4.5m £3.7m £8.4m +20% Gross margin (%) 69.8% 69.1% 70.5%…

Continue reading